157 related articles for article (PubMed ID: 3371856)
1. Bone mineral content of the hyperprolactinemic rat femur by single photon absorptiometry.
Fiore CE; Clementi G; Prato A; Foti R; Conforto G
Horm Metab Res; 1988 Jan; 20(1):40-3. PubMed ID: 3371856
[TBL] [Abstract][Full Text] [Related]
2. Bone density in amenorrheic women with and without hyperprolactinemia.
Schlechte JA; Sherman B; Martin R
J Clin Endocrinol Metab; 1983 Jun; 56(6):1120-3. PubMed ID: 6404918
[TBL] [Abstract][Full Text] [Related]
3. Quantification of bone density and mineral content.
Bentley HB
Radiogr Today; 1989 Jan; 55(620):16-8. PubMed ID: 2590411
[TBL] [Abstract][Full Text] [Related]
4. Increase in bone mass after treatment of hyperprolactinemic amenorrhea.
Klibanski A; Greenspan SL
N Engl J Med; 1986 Aug; 315(9):542-6. PubMed ID: 3736637
[TBL] [Abstract][Full Text] [Related]
5. [A study on bone metabolism in woman with hyperprolactinemia].
Fujimaki T; Kurabayashi T; Ootani T; Yamamoto Y; Yasuda M; Tanaka K
Nihon Sanka Fujinka Gakkai Zasshi; 1994 May; 46(5):423-8. PubMed ID: 8182302
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral content in the senescent rat femur: an assessment using single photon absorptiometry.
Kiebzak GM; Smith R; Howe JC; Sacktor B
J Bone Miner Res; 1988 Jun; 3(3):311-7. PubMed ID: 3213624
[TBL] [Abstract][Full Text] [Related]
7. Comparison of bone density measurements from different skeletal sites.
Seldin DW; Esser PD; Alderson PO
J Nucl Med; 1988 Feb; 29(2):168-73. PubMed ID: 3346733
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral analysis of the rat femur by direct photon absorptiometry.
Sanchez TV; Myers RC; Bond JT; Mayor GH
Calcif Tissue Int; 1981; 33(6):587-90. PubMed ID: 6799170
[TBL] [Abstract][Full Text] [Related]
9. Vertebral bone density in non-amenorrhoeic hyperprolactinaemic women.
Ciccarelli E; Savino L; Carlevatto V; Bertagna A; Isaia GC; Camanni F
Clin Endocrinol (Oxf); 1988 Jan; 28(1):1-6. PubMed ID: 3168298
[TBL] [Abstract][Full Text] [Related]
10. Effects of prolactin and estrogen deficiency in amenorrheic bone loss.
Klibanski A; Biller BM; Rosenthal DI; Schoenfeld DA; Saxe V
J Clin Endocrinol Metab; 1988 Jul; 67(1):124-30. PubMed ID: 3379129
[TBL] [Abstract][Full Text] [Related]
11. Deranged mineral content in the bone of patients with chronic renal failure, estimated by computed tomography.
Marumo F; Sakurai K; Sato N; Shimada H; Iwanami S
Int J Artif Organs; 1985 Mar; 8(2):95-100. PubMed ID: 3988368
[TBL] [Abstract][Full Text] [Related]
12. Osteoporosis in men with hyperprolactinemic hypogonadism.
Greenspan SL; Neer RM; Ridgway EC; Klibanski A
Ann Intern Med; 1986 Jun; 104(6):777-82. PubMed ID: 3706929
[TBL] [Abstract][Full Text] [Related]
13. Errors in longitudinal measurements of bone mineral: effect of source strength in single and dual photon absorptiometry.
Dunn WL; Kan SH; Wahner HW
J Nucl Med; 1987 Nov; 28(11):1751-7. PubMed ID: 3668666
[TBL] [Abstract][Full Text] [Related]
14. Bone-mineral content in the lower limb. Relationship to cross-sectional geometry.
Ruff CB; Hayes WC
J Bone Joint Surg Am; 1984 Sep; 66(7):1024-31. PubMed ID: 6480631
[TBL] [Abstract][Full Text] [Related]
15. Triple-photon energy absorptiometry in the measurement of bone mineral.
Jonson R; Roos B; Hansson T
Acta Radiol; 1988; 29(4):461-4. PubMed ID: 3408608
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral content assessment by photon absorptiometry in a normal population.
Gava A; Patrese P; Zorzetto M
Rays; 1985; 10(2):47-8. PubMed ID: 3843653
[No Abstract] [Full Text] [Related]
17. Bone mineral density (BMD) measurements by photon absorptiometry (PA). An overview.
Wahner HW; Eastell R
Scott Med J; 1986 Jul; 31(3):201-2. PubMed ID: 3798088
[No Abstract] [Full Text] [Related]
18. [Effect of aging on bone mineral content. Part VI. Comparison of bone mineral measurement with single photon absorptiometry and dual photon absorptiometry].
Shiraki M; Inoue J; Ito H; Yamada H; DeSouza AC; Orimo H
Nihon Ronen Igakkai Zasshi; 1988 Nov; 25(6):591-6. PubMed ID: 3241446
[No Abstract] [Full Text] [Related]
19. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
[TBL] [Abstract][Full Text] [Related]
20. Changes in the regulation of calcium metabolism and bone calcium content during growth in the absence of endogenous prolactin and during hyperprolactinemia: a longitudinal study in male and female Wistar rats.
Piyabhan P; Krishnamra N; Limlomwongse L
Can J Physiol Pharmacol; 2000 Oct; 78(10):757-65. PubMed ID: 11077975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
